补佳乐联合米索前列醇对绝经后妇女宫内节育器取出中的作用

目的探讨补佳乐联合米索前列醇对绝经后妇女取节育器的临床效果。方法随机选取2008年1月-2010年10月我院妇产科门诊就诊中绝经后要求取节育器的妇女150例，并随机分两组：研究组75例服补佳乐每日1mg连续5日后行取器术，并于术前2h阴道后穹窿放置米索前列醇400ug，对照组75例为不服用任何药物直接取节育器者。结果在宫颈扩张程度，术中综合反应程度，取节育器时间，取节育器效果方面，研究组均优于对照组两组比较有显著性差异（P〈0．05）。结论补佳乐联合米索前列醇用于妇女绝经后取节育器术成功率高，患者痛苦小，值得临床推广和应用。

the clinic effects on the postmenopausal women removed intrauterine device (IUD) with the Progynova and Misoprostol

Objective to investigate the clinic effects on the postmenopausal women removed intrauterine device （IUD） with the Progynova and Misoprostol Methods 150 eases of post-menopausal women implementated removal of IUD in obstetrics and gynecology clinic from 2008.1-2010.10 were randomly divided into two groups： study group（n=75）（every patient took progynova after 5 days of consecutive daily taking ling and placed 400ug misoprostol in vaginal fornix in 2h before operation）, control group （n=75）（ 75 of cases had not taken any medication before removal of IUD Results the study group had more significantly different than the control group （P 〈0.05） as regard to the cervical dilatation, the degree of intraoperative comprehensive response, the operation time and effect of the removal of IUD Conclusion It is worthy of promotion and application to those postmenopausal women removed intrauterine device with the use of Progynova and misoprostol due to their high success rate and little pain